James Α. Baker

2.2k total citations
66 papers, 1.5k citations indexed

About

James Α. Baker is a scholar working on Ecology, Pharmacology and Molecular Biology. According to data from OpenAlex, James Α. Baker has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ecology, 9 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in James Α. Baker's work include Wildlife Ecology and Conservation (12 papers), Cannabis and Cannabinoid Research (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). James Α. Baker is often cited by papers focused on Wildlife Ecology and Conservation (12 papers), Cannabis and Cannabinoid Research (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). James Α. Baker collaborates with scholars based in United States, United Kingdom and Canada. James Α. Baker's co-authors include John C. Berg, Ian D. Thompson, John M. Fryxell, Herbert C. Maier, Gordon B. Skinner, Arthur Rodgers, David C. Hendrickson, E. Killmann, Douglas E.B. Reid and Philip A. Wiebe and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Langmuir.

In The Last Decade

James Α. Baker

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Α. Baker United States 23 489 218 131 127 126 66 1.5k
John A. Love United States 26 405 0.8× 121 0.6× 11 0.1× 20 0.2× 67 0.5× 54 2.8k
Charles A. Bishop United States 17 175 0.4× 114 0.5× 12 0.1× 45 0.4× 69 0.5× 48 1.5k
Steven L. Richardson United States 16 225 0.5× 66 0.3× 42 0.3× 193 1.5× 290 2.3× 50 1.5k
Tomàs Sintes Spain 20 488 1.0× 97 0.4× 87 0.7× 175 1.4× 129 1.0× 55 1.3k
Anthony J. Giordano United States 28 990 2.0× 38 0.2× 56 0.4× 63 0.5× 198 1.6× 96 2.5k
Maciej Mazur Poland 29 459 0.9× 141 0.6× 132 1.0× 266 2.1× 111 0.9× 106 2.3k
Anna Kozakiewicz Poland 25 264 0.5× 869 4.0× 29 0.2× 263 2.1× 36 0.3× 145 2.1k
Christopher J. Pollock United Kingdom 41 226 0.5× 188 0.9× 103 0.8× 581 4.6× 282 2.2× 129 4.8k
Richard B. Hall United States 34 111 0.2× 92 0.4× 55 0.4× 256 2.0× 352 2.8× 169 3.4k
Richard Hall United States 22 112 0.2× 74 0.3× 57 0.4× 779 6.1× 18 0.1× 43 1.8k

Countries citing papers authored by James Α. Baker

Since Specialization
Citations

This map shows the geographic impact of James Α. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Α. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Α. Baker more than expected).

Fields of papers citing papers by James Α. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Α. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Α. Baker. The network helps show where James Α. Baker may publish in the future.

Co-authorship network of co-authors of James Α. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of James Α. Baker. A scholar is included among the top collaborators of James Α. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Α. Baker. James Α. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grassian, Alexandra, Andrew M. Haidle, James Α. Baker, et al.. (2024). BLU-808, a Potent and Selective Small Molecule Inhibitor of Wild-type c-KIT for Mast Cell Disorders. Journal of Allergy and Clinical Immunology. 153(2). AB62–AB62. 4 indexed citations
2.
Lutz, Ryan, et al.. (2019). Carboxylesterase catalyzed 18O-labeling of carboxylic acid and its potential application in LC-MS/MS based quantification of drug metabolites. Drug Metabolism and Pharmacokinetics. 34(5). 308–316. 8 indexed citations
3.
Baker, James Α., Michael D. Altman, & Iain Martin. (2018). Interpretation of in Vitro Metabolic Stability Studies for Racemic Mixtures. ACS Medicinal Chemistry Letters. 9(8). 843–847. 2 indexed citations
4.
Guo, Jane, Laura Engstrom, Hyun‐Hee Lee, et al.. (2017). A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune system. PLoS ONE. 12(7). e0180870–e0180870. 2 indexed citations
5.
Martin, Iain, et al.. (2016). A Pharmacokinetic Modeling Approach to Predict the Contribution of Active Metabolites to Human Efficacious Dose. Drug Metabolism and Disposition. 44(8). 1435–1440. 1 indexed citations
6.
Lim, Jongwon, Michael D. Altman, James Α. Baker, et al.. (2015). Discovery of 5-Amino- N -(1 H -pyrazol-4-yl)pyrazolo[1,5- a ]pyrimidine-3-carboxamide Inhibitors of IRAK4. ACS Medicinal Chemistry Letters. 6(6). 683–688. 31 indexed citations
7.
Lim, Jongwon, Michael D. Altman, James Α. Baker, et al.. (2015). Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications. Bioorganic & Medicinal Chemistry Letters. 25(22). 5384–5388. 22 indexed citations
8.
Adam, Julia M., John K. Clark, Takao Kiyoi, et al.. (2012). Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 22(8). 2932–2937. 15 indexed citations
9.
Barkey, Henri J., et al.. (2011). Iraq, its neighbors, and the United States : competition, crisis, and the reordering of power. Virtual Defense Library (Ministerio de Defensa). 1 indexed citations
10.
Baker, James Α., Matilda Bingham, Angus R. Brown, et al.. (2011). Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(15). 4622–4628. 2 indexed citations
11.
Morrison, Angus J., Julia M. Adam, James Α. Baker, et al.. (2010). Design, synthesis, and structure–activity relationships of indole-3-heterocycles as agonists of the CB1 receptor. Bioorganic & Medicinal Chemistry Letters. 21(1). 506–509. 13 indexed citations
12.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2010). The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 497–501. 6 indexed citations
13.
Kiyoi, Takao, Mark York, Darren Edwards, et al.. (2010). Design, synthesis, and structure–activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(16). 4918–4921. 11 indexed citations
14.
Baker, James Α., et al.. (2007). The Potential Influence of CO2, as an Agent for Euthanasia, on the Pharmacokinetics of Basic Compounds in Rodents. Drug Metabolism and Disposition. 36(2). 375–379. 19 indexed citations
15.
Baker, James Α. & Lee Hamilton. (2007). Statement by James A. Baker, III, and Lee H. Hamilton, Co-Chairs of the Iraq Study Group Before the Committee on Foreign Relations, United States Senate. Rice University's digital scholarship archive (Rice University).
16.
Martin, Billy R., Jenny L. Wiley, I. P. Beletskaya, et al.. (2006). Pharmacological Characterization of Novel Water-Soluble Cannabinoids. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1230–1239. 26 indexed citations
17.
Kalyuzhnova, Yelena & James Α. Baker. (2002). Energy in the Caspian region : present and future. Palgrave eBooks. 7 indexed citations
18.
Rhys‐Williams, W., et al.. (1997). A mechanistic investigation of the microbial chiral inversion of 2-phenylpropionic acid byVerticillium lecanii. Chirality. 9(3). 254–260. 7 indexed citations
19.
Tan, Soo Choon, James Α. Baker, Vern de Biasi, et al.. (1997). Synthesis, chromatographic resolution and chiroptical properties of carboxyibuprofen stereoisomers: Major metabolites of ibuprofen in man. Chirality. 9(1). 75–87. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Love Breakdown of academic impact, for papers by Charles A. Bishop Breakdown of academic impact, for papers by Steven L. Richardson Breakdown of academic impact, for papers by Tomàs Sintes Breakdown of academic impact, for papers by Anthony J. Giordano Breakdown of academic impact, for papers by Maciej Mazur Breakdown of academic impact, for papers by Anna Kozakiewicz Breakdown of academic impact, for papers by Christopher J. Pollock Breakdown of academic impact, for papers by Richard B. Hall Breakdown of academic impact, for papers by Richard Hall
Rankless by CCL
2026